“Rising Prevalence of gastrointestinal disorders”
- Gastrointestinal (GI) disorders such as colorectal cancer, gastroesophageal reflux disease (GERD), Crohn’s disease, and ulcerative colitis have been rising steadily, becoming a major driver for the gastrointestinal endoscopy market
- These conditions often require early and accurate diagnosis, for which endoscopy remains a primary tool. Colorectal cancer, for instance, ranks among the top causes of cancer-related deaths worldwide, and regular endoscopic screenings such as colonoscopies are vital for early detection and prevention
- Chronic GI diseases such as Crohn’s and GERD necessitate ongoing endoscopic evaluation for disease management and monitoring. The growing prevalence of these conditions, coupled with improved awareness and accessibility of healthcare services, is leading to a surge in demand for gastrointestinal endoscopic procedures across both developed and emerging economies
- Gastrointestinal (GI) disorders are becoming increasingly common worldwide, prompting a greater reliance on endoscopic procedures for accurate diagnosis and effective disease management. Conditions such as Gastroesophageal Reflux Disease (GERD), Crohn’s disease, and colorectal cancer often necessitate timely visual assessment, biopsy, and monitoring, all achievable through endoscopy. With growing awareness, aging populations, and evolving lifestyles, demand for gastrointestinal endoscopy is rising across both developed and emerging regions, positioning it as a cornerstone of modern GI healthcare
